Axel Wester

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 32

Top Topics

Antiplatelet Therapy

St Segment Elevation Myocardial Infarction

Glycemic Control

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Journal of the American Heart Association

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anton Håkansson, Sasha Koul, Elmir Omerovic, Jonas Andersson, Stefan K James, Stefan Agewall, Arash Mokhtari, Jesper van Der Pals, Axel Wester, Karolina Elisabeth Szummer, Tomas Jernberg, David Erlinge, Moman Aladdin Mohammad
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Journal of the American Heart Association 13 (13) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Prof Peter Jepsen, Hannes Hagström
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Anton Håkansson, Sasha Koul, Elmir Omerovic, Jonas Andersson, Stefan K James, Stefan Agewall, Arash Mokhtari, Jesper van Der Pals, Axel Wester, Karolina Elisabeth Szummer, Tomas Jernberg, David Erlinge, Moman Aladdin Mohammad
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Journal of the American Heart Association 13 (13) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Anton Håkansson, Sasha Koul, Elmir Omerovic, Jonas Andersson, Stefan K James, Stefan Agewall, Arash Mokhtari, Jesper van Der Pals, Axel Wester, Karolina Elisabeth Szummer, Tomas Jernberg, David Erlinge, Moman Aladdin Mohammad
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Journal of the American Heart Association 13 (13) (2024)
Anton Håkansson, Sasha Koul, Elmir Omerovic, Jonas Andersson, Stefan K James, Stefan Agewall, Arash Mokhtari, Jesper van Der Pals, Axel Wester, Karolina Elisabeth Szummer, Tomas Jernberg, David Erlinge, Moman Aladdin Mohammad
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Journal of the American Heart Association 13 (13) (2024)
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Hanne Åström, Ying Shang, Hannes Hagström, Axel Wester
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut (2024)
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Anton Håkansson, Sasha Koul, Elmir Omerovic, Jonas Andersson, Stefan K James, Stefan Agewall, Arash Mokhtari, Jesper van Der Pals, Axel Wester, Karolina Elisabeth Szummer, Tomas Jernberg, David Erlinge, Moman Aladdin Mohammad
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Journal of the American Heart Association (2024)
Patrik Nasr, Ying Shang, Axel Wester, Rickard Strandberg, Linnea Widman, Jeffrey Victor Lazarus, Hannes Hagström
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Prof Peter Jepsen, Hannes Hagström
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut (2024)
Ying Shang, Linnea Widman, Fahim Ebrahimi, Jonas F Ludvigsson, Hannes Hagström, Axel Wester
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Johanna Schönau, Axel Wester, Hannes Hagström, Jörn Markus Schattenberg
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis. Journal of internal medicine (2023)
Axel Wester, Ying Shang, Per Stål, Hannes Hagström
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study. Hepatology communications 7 (10) (2023)
Fredrik O Åberg, Ying Shang, Rickard Strandberg, Axel Wester, Linnea Widman, Hannes Hagström
Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients. United European gastroenterology journal (2023)
Mattias Lissing, Axel Wester, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Eliane Sardh, Staffan Wahlin
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients. Journal of inherited metabolic disease (2023)
Johanna Schönau, Axel Wester, Jörn Markus Schattenberg, Hannes Hagström
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study. Journal of internal medicine (2023)
Johanna Schönau, Axel Wester, Jörn Markus Schattenberg, Hannes Hagström
Risk of fractures and post-fracture mortality in 3,980 people with Primary Biliary Cholangitis: A population-based cohort study. Journal of internal medicine (2023)
Axel Wester, Hannes Hagström
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study. Journal of internal medicine 292 (3) (2022)
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Teresa Brevini, Mailis Maes, Gwilym J Webb, Binu V John, Claudia D Fuchs, Gustav Buescher, Lu Wang, Chelsea Griffiths, Marnie L Brown, William E Scott, Pehuén Pereyra-Gerber, William T H Gelson, Stephanie Brown, Scott Dillon, Daniele Muraro, Joanne Sharp, Megan Neary, Helen Box, Lee Tatham, James P Stewart, Paul Curley, Henry Pertinez, Sally Forrest, Petra Mlcochova, Sagar S Varankar, Mahnaz Darvish Damavandi, Victoria L Mulcahy, Rhoda E Kuc, Thomas L Williams, James A Heslop, Davide Rossetti, Olivia C Tysoe, Vasileios Galanakis, Marta Vila-Gonzalez, Thomas W M Crozier, Johannes Bargehr, Sanjay Sinha, Sara S Upponi, Corrina Fear, Lisa Swift, Kourosh Saeb Parsy, Susan E Davies, Axel Wester, Hannes Hagström, Espen Melum, Darran Clements, Peter Humphreys, Jo Herriott, Edyta Kijak, Helen Cox, Chloe Bramwell, Anthony Valentijn, Christopher J R Illingworth, null null, Bassam Dahman, Dustin R Bastaich, Raphaella D Ferreira, Thomas Marjot, Eleanor Barnes, Andrew M Moon, Alfred S Barritt, Ravindra Kumar Gupta, Stephen Baker, Anthony P Davenport, Gareth Corbett, Vassilis G Gorgoulis, Simon James Alexander Buczacki, Joo-Hyeon Lee, Nicholas J Matheson, Michael Trauner, Andrew J Fisher, Paul Gibbs, Andrew J Butler, Christopher J E Watson, George F Mells, Gordon Dougan, Andrew Owen, Ansgar W Lohse, Ludovic Vallier, Fotios Sampaziotis
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature (2022)
Axel Wester, Moman Aladdin Mohammad, Göran Olivecrona, Jasminka Holmqvist, Troels Yndigegn, Sasha Koul
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study. Journal of the American Heart Association 10 (20) (2021)